Back to results
US 2025/0051859 A1Published application
Detection methods
AssigneeBinx Health Limited
InventorsDanny Filer, Claire Ferrao, Sharon Chadwick
Life of this patent
Estimating the term…
Abstract
A method of detecting the presence of Neisseria gonorrhoeae in a sample. The method involves detecting a first target sequence taken from the NGO1642 gene and/or a second target sequence taken from the NGO1012 gene. The method may involve a step of amplifying the target sequence and may involve hybridising the target sequence to a nucleic acid probe and identifying hybridisation. The method may involve simultaneous detection of other target sequences, e.g., from other pathogens.
Claims12
1-58. (canceled)
A cartridge for detection of a pathogen, the cartridge comprising:
- reagents for extraction of nucleic acid from a sample;
- primers that amplify a genetic target from the pathogen to yield amplicons;
- and
- nucleic acid probes that hybridize to the amplicons, the nucleic acid probes including a label that signals when the nucleic acid probes are hybridized to the amplicons, wherein the pathogen comprises C. trachomatis or T. vaginalis, and the primers comprise a forward primer comprising 12 to 29 contiguous nucleotides within SEQ ID NO:
- 18 or 12 to 28 contiguous nucleotides within SEQ ID NO:
- 23.
3 more elements
Dependencies are inferred from the claim text.